PIONEER 1: Randomized Clinical Trial of the Efficacy and Safety of Oral Semaglutide Monotherapy in Comparison With Placebo in Patients With Type 2 Diabetes
Vanita R. Aroda(Brigham and Women's Hospital), Ömür Tabak, Mine Adaş, Ю. Г. Самойлова, Okan Bakıner, Elena Frolova, Osamu Matsuoka, Martin Haluzı́k(Institute of Clinical and Experimental Medicine), Diana Alpenidze, R. Guermaz, Erik Christiansen(National Suicide Research Foundation), Julio Rosenstock(Velocity Clinical Research (United States)), Enrique C. Morales Villegas, Teodora Beljić Živković, S. T. Zyangirova, Ivaylo Lefterov, Ole Kleist Jeppesen(Novo Nordisk (Denmark)), Ludmila Ruyatkina, Tsvetalina Tankova(Medical University of Sofia), Meral Mert, Arihiro Kiyosue, A. D. Dayan, О. Б. Ершова(Yaroslavl State Medical Academy), Hayriye Esra Ataoğlu(Sağlık Bilimleri Üniversitesi), Nabil Chiali, Albina Golovach, Yumiko Ide, Yüksel Altuntaş(Sağlık Bilimleri Üniversitesi), I Penchev, Yasuo Terauchi(Yokohama City University), Katarina Lalić, Anna Rancova, Martina Košková, Samia Bourezane, Mehmet Sargın, Nebojsa M. Lalic(University of Belgrade), Elena Zhdanova, Satoshi Inoue, P Popivanov, Miroslava Hudcova, Krim Belkacem, Enrique Villegas, CHRISTIN L. HERTZ(Novo Nordisk (Denmark)), Nebojša Lalić(Serbian Academy of Sciences and Arts), R. Ortiz, Yasushi Fukushima(Fukuda Denshi (Japan))
Cited by 465
Related Papers
2. Classification and Diagnosis of Diabetes:<i>Standards of Care in Diabetes—2023</i>
|Diabetes Care|2022|2.4k
Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
|Diabetes Care|2022|1.9k
Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
|Diabetologia|2022|986
9. Pharmacologic Approaches to Glycemic Treatment: <i>Standards of Care in Diabetes—2023</i>
|Diabetes Care|2022|850